Literature DB >> 19011881

[Opioids in musculoskeletal pain].

L Siegel1, M Pierer, C Stein, C Baerwald.   

Abstract

Opioids are the most potent analgesics available and are well established for the treatment of severe acute, surgical and cancer pain. Due to their high effectiveness, their use in chronic non-cancer pain (CNCP) is being propagated. However, the use of opioids is still controversial due to their side effects, such as tolerance, addiction or withdrawal, and administrative difficulties associated with their prescription. Chronic rheumatic diseases, in particular low back pain and arthritis, are the leading causes of CNCP. The present article provides a brief overview of the role of opioids in chronic rheumatic diseases, pointing out that a national guideline for opioid use in CNCP is expected at the end of 2008. Furthermore, the peripheral effects of opioids on pain and inflammation in rheumatic diseases will be outlined.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19011881     DOI: 10.1007/s00393-008-0351-0

Source DB:  PubMed          Journal:  Z Rheumatol        ISSN: 0340-1855            Impact factor:   1.372


  26 in total

Review 1.  Attacking pain at its source: new perspectives on opioids.

Authors:  Christoph Stein; Michael Schäfer; Halina Machelska
Journal:  Nat Med       Date:  2003-08       Impact factor: 53.440

Review 2.  Effectiveness of opioids in the treatment of chronic non-cancer pain.

Authors:  Andrea M Trescot; Scott E Glaser; Hans Hansen; Ramsin Benyamin; Samir Patel; Laxmaiah Manchikanti
Journal:  Pain Physician       Date:  2008-03       Impact factor: 4.965

Review 3.  Section 4: treating the patient in pain.

Authors:  Warren A Katz; Russell Rothenberg
Journal:  J Clin Rheumatol       Date:  2005-04       Impact factor: 3.517

4.  Impact of transdermal fentanyl on quality of life in rheumatoid arthritis.

Authors:  Michael N Berliner; Thorsten Giesecke; Karin D Bornhövd
Journal:  Clin J Pain       Date:  2007 Jul-Aug       Impact factor: 3.442

5.  Pain control in inflammation governed by selectins.

Authors:  H Machelska; P J Cabot; S A Mousa; Q Zhang; C Stein
Journal:  Nat Med       Date:  1998-12       Impact factor: 53.440

Review 6.  OARSI recommendations for the management of hip and knee osteoarthritis, Part II: OARSI evidence-based, expert consensus guidelines.

Authors:  W Zhang; R W Moskowitz; G Nuki; S Abramson; R D Altman; N Arden; S Bierma-Zeinstra; K D Brandt; P Croft; M Doherty; M Dougados; M Hochberg; D J Hunter; K Kwoh; L S Lohmander; P Tugwell
Journal:  Osteoarthritis Cartilage       Date:  2008-02       Impact factor: 6.576

7.  Different mechanisms of intrinsic pain inhibition in early and late inflammation.

Authors:  Halina Machelska; Julia K Schopohl; Shaaban A Mousa; Dominika Labuz; Michael Schäfer; Christoph Stein
Journal:  J Neuroimmunol       Date:  2003-08       Impact factor: 3.478

8.  Changing patterns of medication use in patients with rheumatoid arthritis in a Medicaid population.

Authors:  C G Grijalva; C P Chung; C M Stein; E F Mitchel; M R Griffin
Journal:  Rheumatology (Oxford)       Date:  2008-05-22       Impact factor: 7.580

9.  Prescription opioid use among older adults with arthritis or low back pain.

Authors:  Daniel H Solomon; Jerry Avorn; Philip S Wang; George Vaillant; Danielle Cabral; Helen Mogun; Til Stürmer
Journal:  Arthritis Rheum       Date:  2006-02-15

10.  Chronic morphine use does not induce peripheral tolerance in a rat model of inflammatory pain.

Authors:  Christian Zöllner; Shaaban A Mousa; Oliver Fischer; Heike L Rittner; Mohammed Shaqura; Alexander Brack; Mehdi Shakibaei; Waltraud Binder; Florian Urban; Christoph Stein; Michael Schäfer
Journal:  J Clin Invest       Date:  2008-03       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.